Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

N Engl J Med. 2020 Aug 13;383(7):693-694. doi: 10.1056/NEJMc2021840.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Carcinoma, Hepatocellular*
  • Humans
  • Liver Neoplasms*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • atezolizumab